| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |